首页 | 本学科首页   官方微博 | 高级检索  
     


Sorafenib treatment following hematopoietic stem cell transplant in pediatric FLT3/ITD acute myeloid leukemia
Authors:Katherine Tarlock MD  Bill Chang MD  PhD  Todd Cooper DO  Thomas Gross MD  PhD  Sumit Gupta MD  PhD  Steven Neudorf MD  Kathleen Adlard RN  Phoenix A. Ho MD  Suzanne McGoldrick MD  Tanya Watt MD  Tina Templeman RN  India Sisler MD  Amy Garee RN  Blythe Thomson MD  Ann Woolfrey MD  Elihu Estey MD  Soheil Meshinchi MD  PhD  Jessica A. Pollard MD
Affiliation:1. Fred Hutchinson Cancer Research Center, Seattle, Washington;2. Department of Hematology and Oncology, Seattle Children's Hospital, Seattle, Washington;3. Doernbecher Children's Hospital and OHSU Knight Cancer Institute, Oregon Health Science University, Portland, Oregon;4. Aflac Cancer Center and Blood Disorders Center, Children's Healthcare of Atlanta/Emory University, Atlanta, Georgia;5. Nationwide Children's Hospital, Columbus, Ohio;6. Hospital for Sick Children, Toronto, Ontario;7. Children's Hospital of Orange County, Orange, California;8. University of Texas/Southwestern University, Dallas, Texas;9. Virginia Commonwealth University, Richmond, Virginia;10. Epizyme Inc, Cambridge, Massachusetts;11. Maine Children's Cancer Program, Portland, Maine
Abstract:
Keywords:pediatric  acute myeloid leukemia  sorafenib  FLT3/ITD  transplant
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号